Copyright © 2001 by the European Society of Cardiology.
Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia
a Service of Endocrinology and Nutrition, Department of Medicine, Hospital Clinico Universitario, University of Valencia, Valencia, Spain
b Instituto de Investigaciones Citológicas, Valencia, Spain
revised August 1, 2000; accepted August 2, 2000
Abstract
Aims To assess the relationship of the lipid profile to coronary heart disease in a group of heterozygous familial hypercholesterolaemic subjects with similar age, sex, body mass index, prevalence of angiotensin converting enzyme DD genotype and type of low density lipoprotein receptor mutation.
Methods and Results A total of 66 molecularly defined heterozygous familial hypercholesterolaemic subjects, 33 of whom had coronary heart disease, were studied. Clinical features, cardiovascular risk factors and lipid parameters were compared in both groups. Familial hypercholesterolaemic patients with coronary heart disease showed significantly lower values of mean plasma HDL cholesterol and a higher total/HDL cholesterol ratio as compared with familial hypercholesterolaemic subjects free of coronary heart disease. Total and LDL cholesterol concentrations were higher in patients with coronary heart disease, without reaching statistical significance. No differences in plasma lipoprotein(a) levels on absolute and log-transformed values were observed between the two groups. In the whole familial hypercholesterolaemia group, plasma HDL cholesterol levels were related to plasma triglyceride values and to LDL receptor gene ‘null mutations’.
Conclusions In familial hypercholesterolaemic subjects of similar age, gender, body mass index, systolic and diastolic blood pressure, and genetic factors that could influence coronary heart disease risk, plasma HDL cholesterol values and total/HDL cholesterol ratios are two important coronary risk factors. Hence, treatment of familial hypercholesterolaemia should focus not only on lowering total and LDL cholesterol levels, but also on increasing HDL cholesterol values for coronary heart disease prevention. More prospective and intervention trials should be conducted to establish the relationship of HDL cholesterol levels and coronary heart disease in familial hypercholesterolaemia.
Key Words: Heterozygous familial hypercholesterolaemia, HDL cholesterol levels, coronary heart disease, angiotensin converting enzyme DD genotype, low density lipoprotein receptor mutations
f1 Correspondence: Dr Rafael Carmena, Department of Medicine, Hospital Clínico Universitario, Avda. Blasco Ibáñez 17, E-46010 Valencia, Spain.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. K Gebauer, S. G West, C. D Kay, P. Alaupovic, D. Bagshaw, and P. M Kris-Etherton Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study Am. J. Clinical Nutrition, September 1, 2008; 88(3): 651 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Becker, R. Y. Gordon, P. B. Morris, J. Yorko, Y. J. Gordon, M. Li, and N. Iqbal Simvastatin vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial Mayo Clin. Proc., July 1, 2008; 83(7): 758 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. E. MacDonald, R. R. Singaraja, N. Bissada, P. Ruddle, R. Watts, J. M. Karasinska, W. T. Gibson, C. Fievet, J. E. Vance, B. Staels, et al. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice J. Lipid Res., January 1, 2008; 49(1): 217 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Junyent, M. Cofan, I. Nunez, R. Gilabert, D. Zambon, and E. Ros Influence of HDL Cholesterol on Preclinical Carotid Atherosclerosis in Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1107 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Holmes, B. A. Schick, K. H. Humphries, and J. Frohlich Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia Clin. Chem., November 1, 2005; 51(11): 2067 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H A W Neil, V Seagroatt, D J Betteridge, M P Cooper, P N Durrington, J P Miller, M Seed, R P Naoumova, G R Thompson, R Huxley, et al. Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia Heart, December 1, 2004; 90(12): 1431 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review Am. J. Epidemiol., September 1, 2004; 160(5): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Cenarro, M Artieda, S Castillo, P Mozas, G Reyes, D Tejedor, R Alonso, P Mata, M Pocovi, and F Civeira A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia J. Med. Genet., March 1, 2003; 40(3): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Raos and B. J. Strujic Dyslipoproteinemia and Coronary Disease Angiology, September 1, 2002; 53(5): 557 - 562. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Miltiadous, M. A. Cariolou, and M. Elisaf HDL Cholesterol Levels in Patients with Molecularly Defined Familial Hypercholesterolemia Ann. Clin. Lab. Sci., January 1, 2002; 32(1): 50 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Poledne and H. Rosolova Reverse cholestrol transport substantially influences the individual risk of coronary heart disease in hypercholesterolaemic patients Eur. Heart J., March 2, 2001; 22(6): 442 - 443. [PDF]
|
|